The Governors of the University of Calgary
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Private
- Established
- 1966-04-29
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.ucalgary.ca
Comparing Impacts of Donor Human Milk to Formula Supplementation on the Gut Microbiome of Full-term Infants
Not Applicable
Active, not recruiting
- Conditions
- Microbial Colonization
- Interventions
- Other: Donor Human Milk - Nutritional Replacement
- First Posted Date
- 2023-04-18
- Last Posted Date
- 2025-03-27
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 105
- Registration Number
- NCT05815433
- Locations
- 🇨🇦
Rockyview General Hospital, Calgary, Alberta, Canada
Accelerated High-dose Sequential Bilateral Theta Burst Stimulation for Treatment Resistant Depression
Not Applicable
Not yet recruiting
- Conditions
- Treatment Resistant Depression
- Interventions
- Device: Sequential bilateral theta burst stimulation
- First Posted Date
- 2023-04-13
- Last Posted Date
- 2023-04-13
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 40
- Registration Number
- NCT05811104
Body Surface Gastric Mapping to Evaluate Patients With Upper Gastrointestinal Symptoms and Controls
- Conditions
- Functional DyspepsiaDiabetic GastroparesisGastroparesisCannabinoid Hyperemesis SyndromeMotility DisorderCyclical Vomiting
- Interventions
- Device: Gastric Alimetry System
- First Posted Date
- 2023-04-13
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 200
- Registration Number
- NCT05812339
- Locations
- 🇨🇦
University of Calgary, Calgary, Alberta, Canada
POTS Stroke Volume
Not Applicable
Not yet recruiting
- Conditions
- POTS
- Interventions
- Device: ear blood pressure monitor
- First Posted Date
- 2023-04-03
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 30
- Registration Number
- NCT05796154
International Study of Artificial Intelligence-based Diagnosis of Cardiomyopathy Using Cardiac MRI (AID-MRI)
- Conditions
- Cardiomyopathies
- First Posted Date
- 2023-03-31
- Last Posted Date
- 2024-03-13
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 1100
- Registration Number
- NCT05793840
- Locations
- 🇨🇦
Foothills Medical Centre, Calgary, Alberta, Canada
🇨🇦South Health Campus, Calgary, Alberta, Canada
Airway Remodeling and Rhinovirus in Asthmatics
Recruiting
- Conditions
- Respiratory DiseaseAsthma
- Interventions
- Biological: HRV-39
- First Posted Date
- 2023-03-20
- Last Posted Date
- 2024-05-09
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 24
- Registration Number
- NCT05775952
- Locations
- 🇨🇦
University of Calgary, Calgary, Alberta, Canada
Syncope Trial to Understand Tilt Testing or ECG Recording Tenth Prevention of Syncope Trial
Not Applicable
Recruiting
- Conditions
- Syncope
- First Posted Date
- 2023-03-20
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 144
- Registration Number
- NCT05776810
- Locations
- 🇨🇦
University of Calgary, Calgary, Alberta, Canada
HIP Fracture Oral ThromboPROphylaxis (Hip PRO Pilot)
Phase 2
Recruiting
- Conditions
- Hip Fractures
- Interventions
- Drug: acetylsalicylic acid (ASA) 81mg Oral Tablet
- First Posted Date
- 2023-03-20
- Last Posted Date
- 2025-01-14
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 250
- Registration Number
- NCT05775965
- Locations
- 🇨🇦
Royal Columbian Hospital, New Westminster, British Colombia, Canada
🇨🇦The Ottawa Hospital, Ottawa, Ontario, Canada
🇨🇦Foothills Medical Centre, Calgary, Alberta, Canada
Treatment of Lower Leg Anterolateral Chronic Exertional Compartment Syndrome With Intra-muscular Botulinum Injections.
Not Applicable
Not yet recruiting
- Conditions
- Chronic Exertional Compartment Syndrome
- Interventions
- Biological: Normal salineBiological: Botulinum toxin A
- First Posted Date
- 2023-03-13
- Last Posted Date
- 2023-05-17
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 50
- Registration Number
- NCT05765071
A Proof of Principle Study of Ondansetron for the Prevention of Vasovagal Syncope: The Eleventh Prevention of Syncope Trial (POST11)
Phase 2
Recruiting
- Conditions
- Vasovagal Syncope (VVS)Syncope
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-03-06
- Last Posted Date
- 2024-05-10
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 70
- Registration Number
- NCT05755737
- Locations
- 🇨🇦
University of Calgary, Calgary, Alberta, Canada
© Copyright 2025. All Rights Reserved by MedPath